Sabby Management’s iBio IBIO Stock Holding History

Sabby Management’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-149	Closed	-$181K	–	96
2023 Q2	$181K	Sell	149 -26	-15%	-$491	0.15%	51
2023 Q1	$726K	Buy	+175	New	+$4.5K	0.63%	14

Other funds holding IBIO

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sabby Management's IBIO Position: Q2 2024 in Review

Sabby Management sold out of iBio (IBIO) in Q2 2024, closing a stake of 14,000 shares — an estimated $56.8K sold.

Sabby Management first reported a position in IBIO in Q4 2022 and held it in 3 quarters. The position peaked at $242K in Q4 2023. 28 funds tracked by Wall St. Rank hold IBIO as of Q2 2024.

Sabby Management reported no remaining iBio position as of Q2 2024 after selling out during the quarter.
Sabby Management sold 14,000 iBio shares in Q2 2024, an estimated $56.8K.
Sabby Management first reported a position in iBio in Q4 2022 and held it in 3 quarters.
Sabby Management's iBio position peaked at $242K in Q4 2023.
28 funds tracked by Wall St. Rank held iBio as of Q2 2024.

Based on Sabby Management's 13F filing for Q2 2024, filed 14 Aug 2024.